InvestorsHub Logo
Followers 6
Posts 507
Boards Moderated 0
Alias Born 02/29/2008

Re: None

Friday, 09/27/2013 11:59:52 AM

Friday, September 27, 2013 11:59:52 AM

Post# of 499
Omeros spikes on orphan drug designation
Omeros (OMER +3.2%) shares spike after the FDA grants the company an orphan drug designation for its OMS824 antibody for the treatment of Huntington's.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OMER News